Lupus anticoagulant -- finding
|
phenotype |
|
Finding
|
5
|
|
0.100 |
None |
|
0 |
|
|
|
Decreased serum complement C4
|
phenotype |
|
Finding
|
5
|
|
0.100 |
None |
|
0 |
|
|
|
Arthralgia
|
phenotype |
Pathological Conditions, Signs and Symptoms; Musculoskeletal Diseases
|
Sign or Symptom
|
248
|
27
|
0.100 |
None |
|
0 |
|
|
|
ESR raised
|
phenotype |
|
Finding
|
36
|
|
0.100 |
None |
|
0 |
|
|
|
Muscle Weakness
|
phenotype |
Pathological Conditions, Signs and Symptoms; Musculoskeletal Diseases; Nervous System Diseases
|
Sign or Symptom
|
536
|
87
|
0.100 |
None |
|
0 |
|
|
|
Oral Ulcer
|
disease |
Stomatognathic Diseases
|
Disease or Syndrome
|
104
|
101
|
0.100 |
None |
|
0 |
|
|
|
Increased lactate dehydrogenase activity
|
phenotype |
|
Finding
|
27
|
|
0.100 |
None |
|
0 |
|
|
|
Abdominal Pain
|
phenotype |
Pathological Conditions, Signs and Symptoms
|
Sign or Symptom
|
302
|
18
|
0.100 |
None |
|
0 |
|
|
|
Abdomen distended
|
phenotype |
Digestive System Diseases
|
Finding
|
103
|
6
|
0.100 |
None |
|
0 |
|
|
|
Anti-nuclear factor positive
|
phenotype |
Skin and Connective Tissue Diseases
|
Laboratory or Test Result
|
35
|
3
|
0.100 |
None |
|
0 |
|
|
|
Proteinuria
|
phenotype |
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Finding
|
239
|
20
|
0.400 |
None |
1.000 |
1 |
|
2002 |
2002 |
Alveolitis, Fibrosing
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
91
|
4
|
0.300 |
None |
1.000 |
1 |
|
2014 |
2014 |
Liver Neoplasms, Experimental
|
phenotype |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
152
|
|
0.300 |
None |
1.000 |
1 |
|
2001 |
2001 |
Benign neoplasm of brain, unspecified
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
41
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Drug-Induced Acute Liver Injury
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
413
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Drug toxicity
|
group |
Chemically-Induced Disorders
|
Injury or Poisoning
|
86
|
|
0.300 |
None |
1.000 |
1 |
|
2005 |
2005 |
Focal glomerulosclerosis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
281
|
50
|
0.300 |
None |
1.000 |
1 |
|
1997 |
1997 |
Experimental Lung Inflammation
|
disease |
Infections; Respiratory Tract Diseases
|
Experimental Model of Disease
|
54
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Cerebral Hemorrhage
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Cardiovascular Diseases
|
Pathologic Function
|
122
|
78
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Hepatitis, Drug-Induced
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
418
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Hepatoma, Novikoff
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
125
|
|
0.300 |
None |
1.000 |
1 |
|
2001 |
2001 |
Hepatoma, Morris
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
124
|
|
0.300 |
None |
1.000 |
1 |
|
2001 |
2001 |
Hepatitis, Toxic
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
412
|
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Hypersensitivity
|
group |
Immune System Diseases
|
Pathologic Function
|
90
|
2
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Malignant neoplasm of brain
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
294
|
16
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |